🔗 Permalink

Inventor profile of:

Chen Hu

City:

Anhui

Country:

China

Published Applications:

8

Last publication date:

2022-05-12

Top Assignees for applications by Chen Hu

The entities that hold a legal rights for patent applications filed by inventor Hu Chen:

PRECEDO PHARMACEUTICALS CO., LTD 3 Hefei, Anhui, China
HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF SCIENCES 2 Hefei, Anhui, China
HEFEI GRACEVO BIO-MEDICINE CO., LTD 1 Hefei, Anhui, China
TARAPEUTICS SCIENCE INC. 1 Anhui, China
PRECEDO PHARMACEUTICALS CO., LTD 1 Hefei, Annui, China
Hefei Institutes of Physical Science, Chinese Academy of Sciences 1 Anhui, China
HEFEI COSOURCE PHARMACEUTICAL CO., LTD. 1 Hefei, Anhui, China
TARAPEUTICS SCIENCE INC. 1 Bengbu, Anhui Province, China
PRECEDO PHARMACEUTICALS CO., LTD 1 Anhui, China
TARAPEUTICS SCIENCE INC. 1 Bengbu City, Anhui, China
HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF SCIENCES 1 Hefei, Anhui, United States
TARAPEUTICS SCIENCE INC. 1 Bengbu City, China

Recent patent applications by Hu Chen

Chen Hu from Anhui, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-05-12

US20220143001A1

Human necessities

Pan-RAF kinase inhibitor and use thereof

#2 | 2020-10-15

US20200323850A1

Human necessities

Pyrimidine derivative kinase inhibitors

#3 | 2020-01-09

US20200010471A1

Chemistry; metallurgy

Inhibitor of FLT3 kinase and use thereof

#4 | 2019-12-05

US20190367482A1

Chemistry; metallurgy

EZH2 inhibitor and use thereof

#5 | 2019-03-21

US20190084960A1

Chemistry; metallurgy

Selective C-KIT kinase inhibitor

#6 | 2019-02-07

US20190040013A1

Chemistry; metallurgy

Irreversible bruton's tyrosine kinase inhibitor

#7 | 2019-01-10

US20190010159A1

Chemistry; metallurgy

Kinase inhibitor against wild-type and mutant EGFR

#8 | 2018-02-01

US20180030054A1

Chemistry; metallurgy

Inhibitor of FLT3 kinase and use thereof

InventorID:

6019101 ⎘